Unknown

Dataset Information

0

A comparison of interview methods to ascertain fluoroquinolone exposure before tuberculosis diagnosis.


ABSTRACT: SUMMARY Fluoroquinolone use before tuberculosis (TB) diagnosis delays the time to diagnosis and treatment, and increases the risk of fluoroquinolone-resistant TB and death. Ascertainment of fluoroquinolone exposure could identify such high-risk patients. We compared four methods of ascertaining fluoroquinolone exposure in the 6 months prior to TB diagnosis in culture-confirmed TB patients in Tennessee from January 2007 to December 2009. The four methods included a simple questionnaire administered to all TB suspects by health department personnel (FQ-Form), an in-home interview conducted by research staff, outpatient and inpatient medical record review, and TennCare pharmacy database review. Of 177 TB patients included, 72 (41%) received fluoroquinolones during the 6 months before TB diagnosis. Fluoroquinolone exposure determined by review of inpatient and outpatient medical records was considered the gold standard for comparison. The FQ-Form had 61% [95% confidence interval (CI) 48-73] sensitivity and 93% (95% CI 85-98) specificity (agreement 79%, kappa = 0.56) while the in-home interview had 28% (95% CI 18-40) sensitivity and 99% (94-100%) specificity (agreement 68%, kappa = 0.29). A simple questionnaire administered by health department personnel identified fluoroquinolone exposure before TB diagnosis with moderate reliability.

SUBMITTER: Van Der Heijden YF 

PROVIDER: S-EPMC4352378 | biostudies-literature | 2015 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

A comparison of interview methods to ascertain fluoroquinolone exposure before tuberculosis diagnosis.

Van Der Heijden Y F YF   Maruri F F   Holt E E   Mitchel E E   Warkentin J J   Sterling T R TR  

Epidemiology and infection 20141125 5


SUMMARY Fluoroquinolone use before tuberculosis (TB) diagnosis delays the time to diagnosis and treatment, and increases the risk of fluoroquinolone-resistant TB and death. Ascertainment of fluoroquinolone exposure could identify such high-risk patients. We compared four methods of ascertaining fluoroquinolone exposure in the 6 months prior to TB diagnosis in culture-confirmed TB patients in Tennessee from January 2007 to December 2009. The four methods included a simple questionnaire administer  ...[more]

Similar Datasets

| S-EPMC4914627 | biostudies-literature
| S-EPMC2731810 | biostudies-literature
| S-EPMC5075065 | biostudies-literature
| S-EPMC5567202 | biostudies-literature
| S-EPMC2937024 | biostudies-literature
| S-EPMC9387806 | biostudies-literature
| S-EPMC9400435 | biostudies-literature
| S-EPMC6362212 | biostudies-literature
| S-EPMC4271092 | biostudies-literature
| S-EPMC8548760 | biostudies-literature